Cargando…

Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria

BACKGROUND: Deep sequencing could improve understanding of HIV treatment failure and viral population dynamics. However, this tool is often inaccessible in low- and middle-income countries. OBJECTIVES: To determine the genetic patterns of resistance emerging in West African HIV-1 subtypes during fir...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Bouzidi, Kate, Datir, Rawlings P., Kwaghe, Vivian, Roy, Sunando, Frampton, Dan, Breuer, Judith, Ogbanufe, Obinna, Murtala-Ibrahim, Fati, Charurat, Man, Dakum, Patrick, Sabin, Caroline A., Ndembi, Nicaise, Gupta, Ravindra K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809188/ https://www.ncbi.nlm.nih.gov/pubmed/34741609 http://dx.doi.org/10.1093/jac/dkab385

Ejemplares similares

High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment
por: El Bouzidi, Kate, et al.
Publicado: (2020)

Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria
por: Ndembi, Nicaise, et al.
Publicado: (2020)

Baseline PI susceptibility by HIV-1 Gag-protease phenotyping and subsequent virological suppression with PI-based second-line ART in Nigeria
por: Datir, R, et al.
Publicado: (2019)

In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix
por: Datir, Rawlings, et al.
Publicado: (2020)

Correlates and determinants of Early Infant Diagnosis outcomes in North-Central Nigeria
por: Dakum, Patrick, et al.
Publicado: (2019)

Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004–2017)
por: Aliyu, Ahmad, et al.
Publicado: (2019)

Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria
por: Ekong, Ernest, et al.
Publicado: (2020)

A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
por: James, Onyemata E., et al.
Publicado: (2017)

Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread
por: Nazziwa, Jamirah, et al.
Publicado: (2020)

Performance and trend for quality of service in a large HIV/AIDS treatment program in Nigeria
por: Aliyu, Ahmad, et al.
Publicado: (2019)

A3 Molecular epidemiology of HIV-1 in Nigeria
por: Nazziwa, J, et al.
Publicado: (2019)

The Pattern of Attrition from an Antiretroviral Treatment Program in Nigeria
por: Odafe, Solomon, et al.
Publicado: (2012)

Final HIV status outcome for HIV-exposed infants at 18 months of age in nine states and the Federal Capital Territory, Nigeria
por: Adelekan, Babatunde, et al.
Publicado: (2022)

Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study
por: Jumare, Jibreel, et al.
Publicado: (2023)

Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria
por: Odume, B., et al.
Publicado: (2017)

Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors
por: Charurat, Man, et al.
Publicado: (2010)

Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics
por: Volz, Erik M., et al.
Publicado: (2017)

Adherence and retention on antiretroviral therapy in a public-private partnership program in Nigeria
por: Torpey, K, et al.
Publicado: (2012)

Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge
por: Jahun, Ibrahim, et al.
Publicado: (2021)

Rising HIV prevalence among men who have sex with men in Nigeria: a trend analysis
por: Eluwa, George I.E, et al.
Publicado: (2019)

Social barriers in accessing care by clients who returned to HIV care after transient loss to follow-up
por: Adelekan, Babatunde, et al.
Publicado: (2019)

Stigmatization and psychological impact of COVID-19 pandemic on frontline healthcare Workers in Nigeria: a qualitative study
por: Kwaghe, Ayi Vandi, et al.
Publicado: (2021)

Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria
por: Adeyemi, Olusegun A., et al.
Publicado: (2023)

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
por: Gupta, Ravindra K, et al.
Publicado: (2012)

Retention of a cohort of men who have sex with men and transgender women at risk for and living with HIV in Abuja and Lagos, Nigeria: a longitudinal analysis
por: Kayode, Blessing O, et al.
Publicado: (2020)

Willingness to pay for antiretroviral drugs among HIV and AIDS clients in south‐east Nigeria
por: Mbachu, Chinyere, et al.
Publicado: (2017)

Satisfaction with high-resolution anoscopy for anal cancer screening among men who have sex with men: a cross-sectional survey in Abuja, Nigeria
por: Nowak, Rebecca G., et al.
Publicado: (2020)

Effect of community antiretroviral therapy on treatment outcomes among stable antiretroviral therapy patients in Nigeria: A quasi experimental study
por: Dakum, Patrick, et al.
Publicado: (2021)

Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria
por: Avong, Yohanna Kamabi, et al.
Publicado: (2015)

Hepatitis B virus infection among men who have sex with men and transgender women living with or at risk for HIV: a cross sectional study in Abuja and Lagos, Nigeria
por: Adeyemi, Olusegun A., et al.
Publicado: (2021)

Oral sex practices among men who have sex with men and transgender women at risk for and living with HIV in Nigeria
por: Robbins, Sarah J., et al.
Publicado: (2020)

The expansion of pharmaceutical manufacturing industries is critical to strengthen African health systems and decrease reliance on foreign imports
por: Mynhardt, Michael, et al.
Publicado: (2023)

Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response
por: MYNHARDT, MICHAEL, et al.
Publicado: (2023)

Dynamics of the infant gut microbiota in the first 18 months of life: the impact of maternal HIV infection and breastfeeding
por: Grant-Beurmann, Silvia, et al.
Publicado: (2022)

Missed opportunities for early infant diagnosis of HIV in rural North-Central Nigeria: A cascade analysis from the INSPIRE MoMent study
por: Anaba, Udochisom C., et al.
Publicado: (2019)

Outcomes of HIV Positive Children and Adolescents Initiated on Antiretroviral Treatment in Nigeria (2007-2016)
por: Anukam, Onyekachi, et al.
Publicado: (2022)

Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2020)

Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells
por: DeMarino, Catherine, et al.
Publicado: (2018)

Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
por: Anude, Chuka J, et al.
Publicado: (2013)

Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cea54u0gkodt5d35sirafv0tkh